CHARACTERIZATION OF BETA THALASSAEMIA MUTATIONS IN PATIENTS HAVING BORDERLINE HAEMOGLOBIN A2 LEVELS
Journal of Ayub Medical College Abbottabad · 2025
DOI: 10.55519/jamc-04-14046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayub Medical College Abbottabad, 2025. Verfasst von Afshan Noor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: beta-Thalassemia, Hemoglobin A2, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background
The occurrence of a single beta thalassaemia allele is frequently related with microcytic hypochromic red blood cells and a rise in HbA2 levels. In some beta thalassaemia carriers, the outcome of this allele or its collaboration with other acquired or genetic defects may result in normal or borderline Haemoglobin bA2 levels. Objective was to establish the importance of molecular analysis in borderline HbA2 individuals and its significance in a population screening program.
Methods
It was a cross-sectional study conducted over a period of six months, from July-December 2023. All 123 individuals with borderline HbA2 levels between (3‒3.9%) diagnosed by High-performance liquid chromatography (HPLC)/Capillary Zone Electrophoresis underwent molecular testing using multiplex amplification refractory mutation system-Polymerase Chain Reaction (ARMS-PCR) to detect common beta thalassaemia mutations: Fr8-9, IVS1-5, Fr41-42, Cd15, Cd5, IVS1-1, IVS1-1, Cd30, Cd30, Fr16, IVSII-1, Del619, and CAP+1 in the Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi .Statistical tests were applied to compare Red Blood Cell indices and Haemoglobin A2 values among beta thalassaemia carriers and non-carriers.
Results
Among those tested, 47.1% (n=58) were found to carry Beta thalassaemia mutations. The most prevalent mutations were IVS1-5 (n=19,15.4%) and Fr8-9 (n=19,15.4%) followed by Fr41-42 (n=08,6.5%). Subjects with mutations exhibited significantly lower mean corpuscular volume and mean corpuscular haemoglobin compared to those without mutations (p-value=
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan.
- Department of Forensic Medicine, Ayub Medical College, Abbottabad, Pakistan.
Zitieren
APA
Noor, A., Bozdar, M., Malik, H. S., Mahmood, R., Khurshid, A., Khan, A., & Seema, N. (2025). CHARACTERIZATION OF BETA THALASSAEMIA MUTATIONS IN PATIENTS HAVING BORDERLINE HAEMOGLOBIN A2 LEVELS. Journal of Ayub Medical College Abbottabad. https://doi.org/10.55519/jamc-04-14046
Vancouver
Noor A, Bozdar M, Malik HS, Mahmood R, Khurshid A, Khan A, et al. CHARACTERIZATION OF BETA THALASSAEMIA MUTATIONS IN PATIENTS HAVING BORDERLINE HAEMOGLOBIN A2 LEVELS. Journal of Ayub Medical College Abbottabad. 2025. doi:10.55519/jamc-04-14046
BibTeX
@article{Noor2025,
author = {Noor, Afshan and Bozdar, Manzar and Malik, Hamid Saeed and Mahmood, Rafia and Khurshid, Ayesha and Khan, Aysha and Seema, Nighat},
title = {CHARACTERIZATION OF BETA THALASSAEMIA MUTATIONS IN PATIENTS HAVING BORDERLINE HAEMOGLOBIN A2 LEVELS},
journal = {Journal of Ayub Medical College Abbottabad},
year = {2025},
doi = {10.55519/jamc-04-14046}
}
EUVIMED